SECsense Logo

Karyopharm Therapeutics Inc. SEC 8-K Filing Report - January 2025 Update

$KPTI
Form 8-K
Filed on: 2025-01-13
Source
Karyopharm Therapeutics Inc. SEC 8-K Filing Report - January 2025 Update

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Karyopharm Therapeutics Inc.
  • CIK Number: 0001503802
  • SEC File Number: 001-36167
  • Tax ID: 26-3931704
  • Address: 85 Wells Avenue, 2nd Floor, Newton, MA 02459
  • Phone Number: (617) 658-0600
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: January 13, 2025
  1. Stock Information:
  • Common Stock: $0.0001 par value
  • Ticker Symbol: KPTI
  • Exchange: NASDAQ
  1. Period of Reporting:
  • Report Period Start Date: January 13, 2025
  • Report Period End Date: January 13, 2025
  1. XBRL Information:
  • Schema Reference: The document references an XBRL schema located at "kpti-20250113.xsd".

Insights:

  • This filing is an 8-K, which typically indicates significant events or changes that shareholders need to be aware of. The specific nature of the event is not detailed in the provided text.
  • The reporting date and the filing date are the same, which could suggest that the information being disclosed is immediate or related to events occurring on that specific date.
  • Karyopharm Therapeutics Inc. is listed on the NASDAQ under the ticker symbol KPTI, which could be relevant for investors looking to track the stock's performance or news related to the company.

This analysis provides a foundational understanding of Karyopharm Therapeutics Inc.'s recent filing with the SEC and may warrant further investigation into the specific contents of the 8-K filing for more detailed insights.